Showing results (271-280 of 291) with videos related to
Sort By:
Pageof 30
Journal of Biological Regulators and Homeostatic Agents|August 9, 2016
Investigation of the efficacy of Dr Michaels® (Soratinex®) family in maintaining a symptom-free state for patients with psoriasis in remission. A retrospective, comparative studyJ Hercogovấ, M Fioranelli, S Gianfaldoni, et al.Journal of Biological Regulators and Homeostatic Agents|August 9, 2016
Successful treatment of alopecia areata with Dr. Michaels® (Alopinex) product familyU Wollina, J Hercogovấ, M Fioranelli, et al.Journal of Biological Regulators and Homeostatic Agents|August 9, 2016
An innovative, promising topical treatment for psoriasis: a Romanian clinical studyS Gianfaldoni, J Hercogovấ, M Fioranelli, et al.Environmental Technology|November 21, 2014
Pilot-scale evaluation of anammox-based mainstream nitrogen removal from municipal wastewaterT Lotti, R Kleerebezem, Z Hu, et al.Journal of Biological Regulators and Homeostatic Agents|July 5, 2016
Langerhans cell sarcoma: an unusual microscopic presentationA L Gagnon, S Daniel, K Greer, et al.Journal of Biological Regulators and Homeostatic Agents|July 14, 2017
Treatment of skin defects with growth factors and biodegradable collagen carrier: histological evaluation in animal modelP F Nocini, G B Menchini Fabris, F Gelpi, et al.Journal of Biological Regulators and Homeostatic Agents|July 5, 2016
Pilomatrixoma of the breast in a patient with type 1 myotonic dystrophy: successful surgical approachF Fama', A Ieni, G Tchernev, et al.Journal of Biological Regulators and Homeostatic Agents|August 9, 2016
Treatment of ichthyosis lamellaris using a series of herbal skin care products familyM Tirant, P Bayer, J Hercogovấ, et al.Journal of Biological Regulators and Homeostatic Agents|August 9, 2016
Successful treatment of facial systemic lupus erythematosus lesions with Dr Michaels® (Soratinex®) product family. A case reportM Tirant, P Bayer, J Hercogovấ, et al.Journal of Biological Regulators and Homeostatic Agents|July 5, 2016
5-hydroxytryptamine and Lyme disease. Opportunity for a novel therapy to reduce the cerebellar tremor?G K Maximov, K G Maximov, A A Chokoeva, et al.Pageof 30